Thomas Chalberg
Founder at Polymerase Capital
Profile
Thomas W.
Chalberg was the founder of Adverum Biotechnologies, Inc. (founded in 2006) where he served as President, Chief Executive Officer & Director from 2006 to 2015.
He is also the founder of SightGlass Vision, Inc. (founded in 2016) where he was the Chief Executive Officer from 2016 to 2021.
Additionally, he is the founder of Genascence Corp.
(founded in 2017) where he currently holds the position of Chairman, Chief Executive & Financial Officer.
He is also the founder of Polymerase Capital (founded in 2021) where he is the Managing Partner.
Dr. Chalberg's current job(s) include being a Director at Hope for Vision, a Director at ETHRIS GmbH, and an Independent Director at Chameleon Biosciences, Inc.His former job includes being a Director at Verana Health, Inc.Dr. Chalberg's education history includes an undergraduate degree from Harvard University, an MBA from Haas School of Business, and a doctorate from Stanford University School of Medicine.
Thomas Chalberg active positions
| Companies | Position | Start |
|---|---|---|
| Hope for Vision | Director/Board Member | - |
Genascence Corp.
 Genascence Corp. BiotechnologyHealth Technology Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA. | Chief Executive Officer | 01/01/2017 |
| Polymerase Capital | Founder | 01/02/2021 |
ETHRIS GmbH
 ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation. | Director/Board Member | - |
Chameleon Biosciences, Inc.
 Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Director/Board Member | 05/01/2022 |
Former positions of Thomas Chalberg
| Companies | Position | End |
|---|---|---|
SightGlass Vision, Inc.
 SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Chief Executive Officer | 01/07/2021 |
| ADVERUM BIOTECHNOLOGIES, INC. | Founder | 23/07/2015 |
Verana Health, Inc.
 Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Director/Board Member | 01/01/2015 |
Training of Thomas Chalberg
| Harvard University | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
| Stanford University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
| Hope for Vision | |
Verana Health, Inc.
Verana Health, Inc. Packaged SoftwareTechnology Services Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA. | Technology Services |
ETHRIS GmbH
ETHRIS GmbH Miscellaneous Commercial ServicesCommercial Services ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation. | Commercial Services |
SightGlass Vision, Inc.
SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Health Technology |
Chameleon Biosciences, Inc.
Chameleon Biosciences, Inc. BiotechnologyHealth Technology Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA. | Health Technology |
Genascence Corp.
Genascence Corp. BiotechnologyHealth Technology Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA. | Health Technology |
| Polymerase Capital | Finance |
- Stock Market
- Insiders
- Thomas Chalberg
